Loading clinical trials...
Loading clinical trials...
The rate of fluid removal (ultrafiltration, UF) during hemodialysis (HD) may contribute to cardiovascular morbidity and mortality among individuals receiving maintenance HD. More rapid UF rates are associated with higher morbidity and mortality. Ultrafiltration profiling, the practice of varying UF rates to maximize fluid removal during periods of greatest hydration and plasma oncotic pressures, is one treatment modification that may reduce UF-related harm without necessitating reduction in interdialytic fluid intake or longer HD treatments. To date, UF profiling has not been adequately studied independent of sodium profiling. This study investigates the comparative effect of UF profiling versus non-profiled conventional HD on select cardiovascular and patient-reported outcomes. Participants will complete two phases of UF profiling and two phases of conventional HD and will act as their own controls.
Age
18 - 85 years
Sex
ALL
Healthy Volunteers
No
Carolina Dialysis - Carrboro
Carrboro, North Carolina, United States
Carolina Dialysis - Siler City
Siler City, North Carolina, United States
Start Date
March 12, 2018
Primary Completion Date
December 15, 2018
Completion Date
December 18, 2018
Last Updated
May 15, 2020
34
ACTUAL participants
UF profiling during HD
OTHER
Conventional HD
OTHER
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
NCT07146854
NCT04163614
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04580420